Article Details
Retrieved on: 2021-03-05 04:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Overall in clinical trials, the Johnson & Johnson vaccine was 66% effective in preventing moderate to severe COVID-19 in its global Phase 3 trial but 72 ...
Article found on: www.kare11.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here